|
ORC5L expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.75400000002046E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.70379999999892E-05 |
| Normal-vs-Stage2 |
2.781200E-01 |
| Normal-vs-Stage3 |
1.50955999999036E-05 |
| Normal-vs-Stage4 |
1.93119999991609E-07 |
| Stage1-vs-Stage2 |
1.365950E-01 |
| Stage1-vs-Stage3 |
3.458800E-01 |
| Stage1-vs-Stage4 |
5.884000E-02 |
| Stage2-vs-Stage3 |
6.595900E-02 |
| Stage2-vs-Stage4 |
1.399760E-02 |
| Stage3-vs-Stage4 |
2.930000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.27380000003452E-06 |
| Normal-vs-AfricanAmerican |
3.942600E-03 |
| Normal-vs-Asian |
2.040400E-04 |
| Caucasian-vs-AfricanAmerican |
9.213200E-01 |
| Caucasian-vs-Asian |
8.811800E-01 |
| AfricanAmerican-vs-Asian |
9.920200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.236640E-04 |
| Normal-vs-Female |
2.49019999998268E-06 |
| Male-vs-Female |
8.873400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.46579999999552E-05 |
| Normal-vs-Age(41-60Yrs) |
3.7237999999995E-05 |
| Normal-vs-Age(61-80Yrs) |
3.841100E-04 |
| Normal-vs-Age(81-100Yrs) |
3.222900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.774400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.884400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.042400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.814600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.131800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.822200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.714770E-01 |
| Classical-VS-Follicular |
9.590300E-02 |
| Classical-VS-Other |
3.009600E-01 |
| Classical-VS-Normal |
1.68882999999065E-05 |
| Tall-VS-Follicular |
1.573740E-02 |
| Tall-VS-Other |
7.376400E-01 |
| Tall-VS-Normal |
1.64498999999374E-05 |
| Follicular-VS-Other |
2.204600E-01 |
| Follicular-VS-Normal |
5.258200E-02 |
| Other-VS-Normal |
4.837400E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.388000E-04 |
| Normal-vs-N1 |
1.83379999962874E-07 |
| N0-vs-N1 |
5.284000E-03 |
|
|
